Showing results (1-10 of 367) with videos related to
Sort By:
Pageof 37
The Canadian Journal of Cardiology|June 9, 2005
Have angiotensin receptor blockers lived up to expectations?David FitchettThe Canadian Journal of Cardiology|June 28, 2007
The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the riskDavid FitchettExpert Review of Cardiovascular Therapy|August 1, 2008
Tailored antithrombotic therapy for acute coronary syndromesDavid FitchettVascular Health and Risk Management|May 14, 2009
Results of the ONTARGET and TRANSCEND studies: an update and discussionDavid FitchettDiabetes, Obesity & Metabolism|May 14, 2019
A safety update on sodium glucose co-transporter 2 inhibitorsDavid FitchettVascular Health and Risk Management|January 19, 2008
Clinical trial update: focus on the ONTARGET studyDavid FitchettThe Canadian Journal of Cardiology|March 19, 2015
The metabolic syndrome is an important concept in therapeutic decision-makingDavid FitchettThe Lancet. Diabetes & Endocrinology|April 26, 2020
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trialsOlivia R Ghosh-Swaby, Shaun G Goodman, Lawrence A Leiter, et al.Atherosclerosis. Supplements|March 7, 2006
Optimal care of cardiovascular disease and type 2 diabetes patients: shared responsibilities between the cardiologist and diabetologistLawrence A Leiter, David FitchettPhysiology (Bethesda, Md.)|June 18, 2024
Extrarenal Benefits of SGLT2 Inhibitors in the Treatment of CardiomyopathiesVeera Ganesh Yerra, Kim A ConnellyPageof 37